Efficacy and safety of glycoprotein IIb/IIIa inhibitors in addition to P2Y(12) inhibitors in ST-segment elevation myocardial infarction: A subanalysis of the POPular Genetics trial

Anne H. Tavenier, Daniel M. F. Claassens, Renicus S. Hermanides, Gerrit J. A. Vos, Thomas O. Bergmeijer, Johannes C. Kelder, Vera H. M. Deneer, Arnoud W. J. van 't Hof, Jurrien M. Ten Berg

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Number of pages10
JournalCatheterization and Cardiovascular interventions
DOIs
Publication statusE-pub ahead of print - 7 Jul 2021

Keywords

  • clopidogrel
  • glycoprotein IIb
  • IIIa inhibitors
  • primary percutaneous coronary intervention
  • STEMI
  • ticagrelor
  • PERCUTANEOUS CORONARY INTERVENTION
  • INDIVIDUAL PATIENTS DATA
  • IIB-IIIA INHIBITORS
  • HIGH-DOSE TIROFIBAN
  • PRIMARY ANGIOPLASTY
  • PREHOSPITAL INITIATION
  • STENT THROMBOSIS
  • FEMORAL ACCESS
  • TASK-FORCE
  • LONG

Cite this